To clarify the biological role of FBXO22 in lung cancer radiotherapy, we silenced the expression of FBXO22 with two different methods (SiRNA and CRISPR-Cas9 technology) (Fig. 2A and Fig. S1A). The gene discussed is FBXO22; the disease is lung cancer.